½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1441281

¼¼°èÀÇ ¸ðÀ¯ ¿Ã¸®°í´ç(HMO) ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼®, À¯Çüº°, ¿ëµµº°, »ê¾÷º° - »ê¾÷ ¿¹Ãø(2023-2030³â)

Global Human Milk Oligosaccharides (HMO) Market Size, Share, Growth Analysis, By Type(2¢¥-FL & 3-FL, Sialyllactose), By Application(Segmented as, Infant Formula) - Industry Forecast 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: SkyQuest | ÆäÀÌÁö Á¤º¸: ¿µ¹® 157 Pages | ¹è¼Û¾È³» : 3-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¸ðÀ¯ ¿Ã¸®°í´ç(HMO) ½ÃÀå ±Ô¸ð´Â 2022³â 1¾ï 7,791¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø ±â°£(2024-2031³â) µ¿¾È ¿¬Æò±Õ 9.7%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 2023³â 1¾ï 9,517¸¸ ´Þ·¯¿¡¼­ 2031³â±îÁö 4¾ï 932¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ðÀ¯ ¿Ã¸®°í´ç(HMO) ½ÃÀåÀº ¿µÀ¯¾ÆÀÇ °Ç°­°ú ¿µ¾ç¿¡ ÀÖ¾î Áß¿äÇÑ ¼ººÐÀ¸·Î °¢±¤¹Þ°í ÀÖ½À´Ï´Ù. º¹ÇÕ´ç·ù·Î ºÐ·ùµÇ´Â HMO´Â ¸ðÀ¯¿¡ ÀÚ¿¬ÀûÀ¸·Î Á¸ÀçÇÏ¸ç ´Ù¾çÇÑ °Ç°­»óÀÇ ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. HMO¿¡ ´ëÇÑ ÀÌÇصµ°¡ ³ô¾ÆÁü¿¡ µû¶ó HMOÀÇ ÀáÀçÀû È°¿ë °¡´É¼ºÀº À¯¾Æ ¿µ¾çÇлӸ¸ ¾Æ´Ï¶ó ÀÇ·á, ±â´É¼º ½ÄÇ°, ÇÁ¸®¹ÙÀÌ¿Àƽ½º º¸ÃæÁ¦ µî ´Ù¾çÇÑ ºÐ¾ß·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÇýÅÿ¡ ´ëÇÑ ´ëÁßÀÇ ÀÎ½Ä Áõ°¡¿Í ¸ðÀ¯¿¡ ´õ °¡±õ°Ô Á¶Á¦ºÐÀ¯¸¦ ¸¸µé·Á´Â ¸ñÀûÀÌ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä µ¿ÀÎÀÔ´Ï´Ù. ¸é¿ª ¹× Àå °Ç°­À» °­È­ÇÏ´Â HMOÀÇ ´É·ÂÀº ÀÚ¿¬ÀûÀÌ°í Àüü·ÐÀûÀÎ Ä¡·á¹ýÀ» Ãß±¸ÇÏ´Â Ãß¼¼¿Í ÀÏÄ¡ÇÕ´Ï´Ù. ¿¬±¸ °³¹ß¿¡´Â ƯÁ¤ °Ç°­»óÀÇ ÀÌÁ¡À» ¸ñÇ¥·Î ÇÏ´Â °íÀ¯ÇÑ HMO ¼ººÐÀÇ ½Äº° ¹× °³¹ßµµ Æ÷ÇԵ˴ϴÙ. ±×·¯³ª HMO »ý»êÀÇ º¹À⼺°ú ºñ¿ë, ƯÈ÷ ¸ðÀ¯¿¡ Á¸ÀçÇÏ´Â ´Ù¾çÇÑ HMO¸¦ º¹Á¦ÇÏ´Â µ¥´Â ¾î·Á¿òÀÌ µû¸¨´Ï´Ù. ±ÔÁ¦ °í·Á »çÇ×°ú ÀáÀçÀûÀÎ ÁöÀû Àç»ê±Ç Àå¾Ö¹°µµ ½ÃÀå ¿ªÇп¡ ¿µÇâÀ» ¹ÌÄ¡¸ç, HMO¿¡ ´ëÇÑ ¿¬±¸°¡ ÁøÇàµÊ¿¡ µû¶ó ½ÃÀåÀº À¯¾Æ ¿µ¾ç»Ó¸¸ ¾Æ´Ï¶ó ´Ù¾çÇÑ »ý¾Ö ´Ü°èÀÇ ´Ù¾çÇÑ °Ç°­ ¿ä±¸ »çÇ×À» ÃæÁ·½ÃÅ°´Â µ¥¿¡µµ À¯¸ÁÇÑ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¿µ¾ç°ú °Ç°­ÀÇ °³³äÀ» ÀçÁ¤ÀÇÇÒ ¼ö ÀÖ´Â °¡´É¼ºÀº ÀÇ·á ¹× ±â´É¼º ½ÄÇ°ÀÇ ¹Ì·¡¸¦ Çü¼ºÇÏ´Â µ¥ ÀÖ¾î HMO ½ÃÀåÀÇ Á߿伺À» °­Á¶ÇÕ´Ï´Ù.

¸ñÂ÷

ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä
  • ¹ø¿µ°ú ¼èÅð

Á¶»ç ¹æ¹ý

  • Á¤º¸ Á¶´Þ
  • 2Â÷/1Â÷ Á¤º¸¿ø
  • ½ÃÀå ±Ô¸ð ÃßÁ¤
  • ½ÃÀå ÀüÁ¦Á¶°Ç°ú Á¦ÇÑ

»óÀ§ ½ÃÀå ºÐ¼®

  • ½ÃÀå °³¿ä
  • ½ÃÀå ±Ô¸ð
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ±âȸ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °úÁ¦

ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®

  • ±â¼ú ºÐ¼®
  • °¡°Ý ºÐ¼®
  • °ø±Þ¸Á ºÐ¼®
  • ¹ë·ùüÀÎ ºÐ¼®
  • ½ÃÀå »ýÅ°è
  • IP ºÐ¼®
  • ¹«¿ª ºÐ¼®
  • ½ºÅ¸Æ®¾÷ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
  • Çõ½Å ¸ÅÆ®¸¯½º
  • ÆÄÀÌÇÁ¶óÀÎ Á¦Ç° ºÐ¼®
  • °Å½Ã°æÁ¦ ÁöÇ¥
  • ÁÖ¿ä ÅõÀÚ ºÐ¼®
  • ÁÖ¿ä ¼º°ø ¿äÀÎ
  • °æÀï Á¤µµ

½ÃÀå ¿ªÇаú Àü¸Á

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ±âȸ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °úÁ¦
  • ±ÔÁ¦ »óȲ
  • PorterÀÇ Five Forces ºÐ¼®
  • ÇâÈÄ È¥¶õ¿¡ °üÇÑ Æ¯º° ÀλçÀÌÆ®

¼¼°èÀÇ ¸ðÀ¯ ¿Ã¸®°í´ç(HMO) ½ÃÀå : À¯Çüº°

  • ½ÃÀå °³¿ä
  • 2'-FL & 3-FL
  • Sialyllactose
  • LNT & LNnT

¼¼°èÀÇ ¸ðÀ¯ ¿Ã¸®°í´ç(HMO) ½ÃÀå : ¿ëµµº°

  • ½ÃÀå °³¿ä
  • À¯¾Æ¿ë Á¶Á¦ºÐÀ¯
  • ±â´É¼º ½ÄÇ° ¹× À½·á
  • ½ÄÇ°/ÀÇ·á º¸ÃæÁ¦
  • ±âŸ

¼¼°èÀÇ ¸ðÀ¯ ¿Ã¸®°í´ç(HMO) ½ÃÀå ±Ô¸ð : Áö¿ªº°

  • ½ÃÀå °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ½ºÆäÀÎ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • GCC ±¹°¡
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

°æÀï ±¸µµ

  • ÁÖ¿ä 5°³»ç ºñ±³
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×(2021³â)
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÌ Ã¤ÅÃÇÑ Àü·«
  • ÁÖ¿ä ¼º°ø Àü·«
  • ½ÃÀå¿¡¼­ÀÇ ÃÖ±Ù È°µ¿
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À²(2021³â)

ÁÖ¿ä ±â¾÷ °³¿ä

  • DuPont Nutrition & Biosciences
  • Nestle S.A.
  • Glycosyn LLC
  • Jennewein Biotechnologie GmbH
  • Elicityl
  • Inbiose
  • ZuChem Inc.
  • Glycom A/S
  • TMO Renewables Ltd.
  • Abbott Laboratories
  • Evolve Biosystems
  • Quantum Biotechnologies Inc.
  • Novalac
  • ZuChem Inc.
  • Clasado Biosciences
  • Metabiotics Corporation
  • Medolac Laboratories
  • HMO Research GmbH
  • Jennewein Biotechnologie
  • Holton BioSystems
LSH 24.04.11

Global Human Milk Oligosaccharides (HMO) Market size was valued at USD 177.91 Million in 2022 and is poised to grow from USD 195.17 Million in 2023 to USD 409.32 Million by 2031, at a CAGR of 9.7% during the forecast period (2024-2031).

The market for human milk oligosaccharides (HMOs) is gaining prominence as a crucial component in infant wellness and nutrition. HMOs, categorized as complex carbohydrates, naturally occur in human breast milk and offer various health benefits. These bioactive compounds support the development of the infant's immune system, gastrointestinal health, and cognitive functions. As our understanding of HMOs expands, their potential applications extend beyond infant nutrition to fields like medicine, functional foods, and prebiotic supplements. Increasing public awareness of the health benefits of HMOs and the aim to make infant formula more akin to breast milk are key drivers of market growth. The ability of HMOs to enhance immunological and gut health aligns with the rising trend of seeking natural and holistic remedies. Research focus also includes identifying and developing unique HMO compositions to target specific health benefits. However, challenges in HMO production complexity and cost arise, particularly in replicating the diverse range of HMOs present in breast milk. Regulatory considerations and potential intellectual property obstacles also influence market dynamics. As research on HMOs advances, the market shows promise not just in infant nutrition but also in addressing various health needs across different stages of life. The potential to redefine the concept of nutrition and well-being underscores the significance of the HMO market in shaping the future of healthcare and functional foods.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Human Milk Oligosaccharides (HMO) and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Human Milk Oligosaccharides (HMO) Market Segmental Analysis

The Human Milk Oligosaccharides (HMO) Market is segmented on the basis of Type, Application, and Region. Based on Type, the market is segmented as, 2'-FL & 3-FL, Sialyllactose, LNT & LNnT. Based on Application the market is segmented as, Infant Formula, Functional Food & Beverages, Food/Medical Supplements, Others. Regional the market is segmented as, North America, Asia Pacific, Latin America, and Middle East & Africa (MEA)

Drivers of the Global Human Milk Oligosaccharides (HMO) Market

The increasing recognition of the health benefits of human milk oligosaccharides (HMOs) is a significant driver for market growth. There is a rising demand for HMO-fortified products due to the role HMOs play in enhancing the immune system, cognitive development, and gut health in infants, as well as potential benefits for adults.

The incorporation of HMOs in formula products reflects consumers' desire for infant formulas that closely mimic the health advantages of breast milk. HMOs have become a vital component of infant nutrition as parents seek to provide their babies with optimal nourishment.

Restraints in the Global Human Milk Oligosaccharides (HMO) Market

The synthesis of HMOs is a challenging and intricate process. The scalability and cost-efficiency of manufacturing HMOs are hindered by the intricate and expensive methods required to replicate the diverse array of HMO structures found in breast milk.

It is essential to educate consumers about the benefits and importance of HMOs, especially in non-infant applications. While challenging, increasing awareness and understanding of the potential uses of HMOs is crucial for market growth.

Market Trends of the Global Human Milk Oligosaccharides (HMO) Market

Exploring Diverse Applications Beyond Infant Nutrition: While HMOs have traditionally been associated with infant feeding and are naturally present in breast milk, there is a growing trend to explore their potential in various other contexts. Researchers are investigating the use of HMOs in functional foods, dietary supplements, and pharmaceuticals to address a range of health conditions across different age groups.

Customization and HMO Profiling: As scientific understanding of HMOs advances, an increasing number of HMO profiles are being developed to closely mimic the composition of HMOs found in the breast milk of specific mothers. This customization offers the potential to provide new-borns with personalized nutrition tailored to their individual needs, as each mother's milk has a unique HMO composition.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Human Milk Oligosaccharides (HMO) Market by Type

  • Market Overview
  • 2'-FL & 3-FL
  • Sialyllactose
  • LNT & LNnT

Global Human Milk Oligosaccharides (HMO) Market by Application

  • Market Overview
  • Segmented as
  • Infant Formula
  • Functional Food & Beverages
  • Food/Medical Supplements
  • and Others

Global Human Milk Oligosaccharides (HMO) Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • DuPont Nutrition & Biosciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nestle S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Glycosyn LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jennewein Biotechnologie GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elicityl
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inbiose
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ZuChem Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Glycom A/S
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TMO Renewables Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Evolve Biosystems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quantum Biotechnologies Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novalac
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ZuChem Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Clasado Biosciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Metabiotics Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medolac Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HMO Research GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jennewein Biotechnologie
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Holton BioSystems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦